胸主動脈瘤市場－全球產業規模、佔有率、趨勢、機會和預測（按治療、最終用途、地區和競爭細分，2020-2030 年）

2024年，全球胸主動脈瘤市場規模為32.8億美元，預計2030年將達76.1億美元，複合年成長率為4.77%。這得益於心血管疾病盛行率的上升、診斷技術的進步以及人們對早期發現和治療的認知的提高。胸主動脈瘤的特徵是胸部主動脈異常膨出，如果不及時治療，將帶來嚴重的健康風險，包括危及生命的破裂。

微創手術技術（例如血管內動脈瘤修復術 (EVAR)）的創新推動了市場擴張，與傳統的開放性手術相比，該技術提供了更安全、更有效的治療選擇。關鍵挑戰包括先進手術程序和設備的高昂成本，以及某些地區專業醫療機構的可及性有限，這些因素可能會限制市場滲透。

關鍵市場促進因素

醫療保健產業的成長

主要市場挑戰

診斷較晚且無症狀

主要市場趨勢

先進的臨床實踐和個人化治療

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球胸主動脈瘤市場的影響

第5章：全球胸主動脈瘤市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依治療方法（開放性手術修復 (OSR)、胸主動脈瘤腔內修復 (TEVAR)、混合手術、分支型血管內動脈瘤修復 (BEVAR)、其他）
  • 依最終用途（醫院、門診手術中心 (ASC)、診所、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美胸主動脈瘤市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲胸主動脈瘤市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第 8 章：亞太地區胸主動脈瘤市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美胸主動脈瘤市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲胸主動脈瘤市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：全球胸主動脈瘤市場：SWOT 分析

第 15 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 16 章：競爭格局

• Medtronic plc
• WL Gore & Associates, Inc.
• Cook Medical Inc.
• Terumo Corporation
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• Artivion Inc.
• Cardiatis SA
• Endologix Inc.
• Braile Biomedica

第 17 章：策略建議

第18章調查會社について,免責事項

Global Thoracic Aortic Aneurysm Market was valued at USD 3.28 Billion in 2024 and is expected to reach USD 7.61 Billion by 2030 with a CAGR of 4.77%. This is driven by increasing prevalence of cardiovascular diseases, advances in diagnostic technologies, and rising awareness about early detection and treatment. Thoracic aortic aneurysm, characterized by the abnormal bulging of the aorta in the chest region, poses significant health risks including life-threatening ruptures if left untreated.

Market expansion is supported by technological innovations in minimally invasive surgical techniques, such as endovascular aneurysm repair (EVAR), which offer safer and more effective treatment options compared to traditional open surgery. Key challenges include the high cost of advanced surgical procedures and devices, as well as limited accessibility to specialized healthcare facilities in certain regions, which may restrict market penetration.

Key Market Drivers

Growth in Healthcare Industry

The rapid growth of the global healthcare industry is a significant driver propelling the expansion of the thoracic aortic aneurysm (TAA) market. The global healthcare industry generates annual sales exceeding USD 4 trillion. The largest and most lucrative segments are pharmaceuticals and biotechnology, accounting for nearly USD 850 billion, and medical technology and diagnostics, which exceed USD 400 billion in revenue. Increased healthcare expenditure, advancements in diagnostic technologies, and the rising prevalence of cardiovascular diseases are collectively fueling demand for effective TAA detection and treatment solutions worldwide.

As healthcare infrastructure improves globally, more patients are gaining access to specialized cardiovascular care, leading to higher diagnosis rates and increased adoption of surgical and minimally invasive interventions for thoracic aortic aneurysms. The PEN-Plus strategy decentralizes specialized cardiovascular care to district hospitals by reallocating responsibilities to multidisciplinary teams of midlevel professionals. It aims to ensure sustainability by enhancing health literacy to encourage self-management, leveraging community health workers to improve patient retention, engaging peer-support groups, and establishing clear referral and counter-referral pathways for patients with cardiovascular disease (CVD). Furthermore, growing awareness about cardiovascular health and early screening initiatives are contributing to market growth.

Key Market Challenges

Late Diagnosis and Asymptomatic Nature

One of the primary challenges confronting the global thoracic aortic aneurysm market is the condition's asymptomatic nature, which often leads to late diagnosis. Many patients with thoracic aortic aneurysms remain unaware of their condition until symptoms manifest in advanced stages or until life-threatening complications, such as aortic rupture or dissection, occur. This silent progression significantly complicates timely intervention and treatment.

The lack of early, noticeable symptoms poses a major barrier for healthcare providers in identifying at-risk individuals before critical damage occurs. Consequently, patients frequently present with the disease at a stage when therapeutic options are more complex, invasive, and associated with higher risks. Moreover, limited awareness among the general population and inadequate routine screening protocols contribute to delayed detection.

Key Market Trends

Advanced Clinical Practices and Personalized Treatment

The adoption of advanced clinical practices and personalized treatment approaches is a key trend shaping the global thoracic aortic aneurysm (TAA) market. Open-chest thoracic aortic aneurysm repair continues to be the standard surgical treatment for thoracic aortic aneurysms (TAAs), representing the established approach for managing this condition. This procedure remains the preferred method due to its proven effectiveness in addressing complex aneurysms within the thoracic aorta. Innovations in diagnostic imaging, genetic profiling, and minimally invasive surgical techniques are enabling healthcare providers to tailor interventions more precisely to individual patient needs.

Personalized treatment strategies, supported by enhanced risk assessment tools and patient-specific data, are improving the accuracy of aneurysm detection, monitoring, and management. This approach reduces complications, optimizes therapeutic outcomes, and enhances patient quality of life. Moreover, the integration of multidisciplinary care teams and the use of advanced endovascular devices reflect a broader shift towards precision medicine in TAA treatment.

Key Market Players

• Medtronic plc
• W.L. Gore & Associates, Inc.
• Cook Medical Inc.
• Terumo Corporation
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• Artivion Inc.
• Cardiatis S.A.
• Endologix Inc.
• Braile Biomedica

Report Scope

In this report, the Global Thoracic Aortic Aneurysm Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Thoracic Aortic Aneurysm Market, By Treatment:

• Open Surgical Repair (OSR)
• Thoracic Endovascular Aneurysm Repair (TEVAR)
• Hybrid Procedures
• Branched Endovascular Aneurysm Repair (BEVAR)
• Others

Thoracic Aortic Aneurysm Market, By End Use:

• Hospitals
• Ambulatory surgery centers (ASC)
• Clinics
• Others

Thoracic Aortic Aneurysm Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Thoracic Aortic Aneurysm Market.

Available Customizations:

Global Thoracic Aortic Aneurysm Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Thoracic Aortic Aneurysm Market

5. Global Thoracic Aortic Aneurysm Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment (Open Surgical Repair (OSR), Thoracic Endovascular Aneurysm Repair (TEVAR), Hybrid Procedures, Branched Endovascular Aneurysm Repair (BEVAR), Others)
  • 5.2.2. By End Use (Hospitals, Ambulatory surgery centers (ASC), Clinics, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Thoracic Aortic Aneurysm Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Thoracic Aortic Aneurysm Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Thoracic Aortic Aneurysm Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Thoracic Aortic Aneurysm Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment
      • 6.3.3.2.2. By End Use

7. Europe Thoracic Aortic Aneurysm Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Thoracic Aortic Aneurysm Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Thoracic Aortic Aneurysm Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Thoracic Aortic Aneurysm Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Thoracic Aortic Aneurysm Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Treatment
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Thoracic Aortic Aneurysm Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Treatment
      • 7.3.5.2.2. By End Use

8. Asia Pacific Thoracic Aortic Aneurysm Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Thoracic Aortic Aneurysm Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Thoracic Aortic Aneurysm Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Thoracic Aortic Aneurysm Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Thoracic Aortic Aneurysm Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Treatment
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Thoracic Aortic Aneurysm Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Treatment
      • 8.3.5.2.2. By End Use

9. South America Thoracic Aortic Aneurysm Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Thoracic Aortic Aneurysm Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Thoracic Aortic Aneurysm Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Thoracic Aortic Aneurysm Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Thoracic Aortic Aneurysm Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Treatment
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Thoracic Aortic Aneurysm Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Treatment
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Thoracic Aortic Aneurysm Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Treatment
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Thoracic Aortic Aneurysm Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Treatment
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Global Thoracic Aortic Aneurysm Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Medtronic plc
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. W.L. Gore & Associates, Inc.
• 16.3. Cook Medical Inc.
• 16.4. Terumo Corporation
• 16.5. MicroPort Scientific Corporation
• 16.6. Boston Scientific Corporation
• 16.7. Artivion Inc.
• 16.8. Cardiatis S.A.
• 16.9. Endologix Inc.
• 16.10. Braile Biomedica

17. Strategic Recommendations

18. About Us & Disclaimer